GILD and BMY Related Headlines
Go Back- Barclays launches U.S. biopharma coverage with four preferred picks
- 14 of 17 Leading Drug Manufactures Now Part of Trump Most Favored Nation Efforts
- Bernstein on AmericasMedicines.com: 'The Noise Starts, But Not (Yet) from Trump'
- Trump demands pharma CEOs lower drug prices within 60 days
- Trump Posts Letters to Regeneron, Merck, AstraZeneca, GSK, Pfizer, Novo Nordisk, Amgen, Bristol-Myears, AbbVie, Novartis, Gilead, J&J on Truth Social
